Considering 30-days investment horizon, BristolMyers Squibb Company is expected to generate 0.54 times more return on investment than SanofiAventis. However, BristolMyers Squibb Company is 1.85 times less risky than SanofiAventis. It trades about -0.23 of its potential returns per unit of risk. SanofiAventis is currently generating about -0.3 per unit of risk. If you would invest 3,376 in BristolMyers Squibb Company on April 25, 2012 and sell it today you would lose (77.00) from holding BristolMyers Squibb Company or give up 2.28% of portfolio value over 30 days.
Diversification
Good diversification
Overlapping area represents amount of risk that can be diversified away by holding BristolMyers Squibb Company and SanofiAventis in the same portfolio (assuming nothing else is changed)
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
